Transforming patient care
With its CE-marked and FDA-approved solution icobrain by icometrix is positively transforming patient care through imaging AI. Icobrain quantifies clinically relevant brain structures in individual patients who are suffering from neurological disorders such as multiple sclerosis, dementia or TBI. Icompanion, in turn, is a platform that supports MS patients and enriches the imaging data with real world input.
As one of the first European digital healthcare companies, icometrix has been at the forefront of using AI for the analysis of brain scans, turning imaging data into actionable insights for clinicians, pharma companies and funders.